Renaissance Technologies
FRLN

Renaissance Technologies’s Freeline Therapeutics Holdings plc American Depositary Shares FRLN Stock Holding History

Renaissance Technologies’s Portfolio FRLN Stock Details FRLN Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
2023
Q4 		$220K Buy
2023
Q3 		$113K Buy
2023
Q2 		$56K Buy
2023
Q1 		$105K Buy
2022
Q4 		$93K Sell
2022
Q3 		$150K Sell
2022
Q2 		$231K Sell
2022
Q1 		$500K Buy
2021
Q4 		$416K Buy
2021
Q3 		$663K Buy